Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary : Global COPD Drug Delivery Devices Market


4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global COPD Drug Delivery Devices Market Analysis and Forecast, 2017–2027


5. Key Insights

5.1. Disease Prevalence in Key Countries

5.2. Key Market Events

5.3. Regulatory Scenario


6. Global COPD Drug Delivery Devices Market Analysis and Forecasts, by Product

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

6.3.1. Inhaler

6.3.1.1. Metered Dose Inhaler

6.3.1.2. Dry Powder Inhaler

6.3.1.3. Soft Mist Inhaler

6.3.2. Nebulizer

6.3.2.1. Jet Nebulizer

6.3.2.2. Mesh Nebulizer

6.3.2.3. Ultrasonic Nebulizer

6.4. Global COPD Drug Delivery Devices Market Attractiveness, by Product


7. Global COPD Drug Delivery Devices Market Analysis and Forecasts, by Type

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Global COPD Drug Delivery Devices Market Value (US$) Forecast, by Type, 2017–2027

7.3.1. Manual Device

7.3.2. Digital Device

7.4. Global COPD Drug Delivery Devices Market Attractiveness, by Type


8. Global COPD Drug Delivery Devices Market Analysis and Forecasts, by Distribution Channel

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

8.3.1. Hospital Pharmacies

8.3.2. Retail Pharmacies

8.3.3. Online Pharmacies

8.4. Global COPD Drug Delivery Devices Market Attractiveness, by Distribution Channel


9. Global COPD Drug Delivery Devices Market Analysis and Forecasts, by Region

9.1. Key Findings

9.2. Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Global COPD Drug Delivery Devices Market Attractiveness, by Region


10. North America COPD Drug Delivery Devices Market Analysis and Forecast

10.1. Introduction

10.2. North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

10.2.1. Inhaler

10.2.1.1. Metered Dose Inhaler

10.2.1.2. Dry Powder Inhaler

10.2.1.3. Soft Mist Inhaler

10.2.2. Nebulizer

10.2.2.1. Jet Nebulizer

10.2.2.2. Mesh Nebulizer

10.2.2.3. Ultrasonic Nebulizer

10.3. North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027

10.3.1. Manual Device

10.3.2. Digital Device

10.4. North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

10.4.1. Hospital Pharmacies

10.4.2. Retail Pharmacies

10.4.3. Online Pharmacies

10.5. North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

10.5.1. U.S.

10.5.2. Canada

10.6. North America COPD Drug Delivery Devices Market Attractiveness Analysis

10.6.1. By Product

10.6.2. By Type

10.6.3. By Distribution Channel

10.6.4. By Country


11. Europe COPD Drug Delivery Devices Market Analysis and Forecast

11.1. Introduction

11.2. Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

11.2.1. Inhaler

11.2.1.1. Metered Dose Inhaler

11.2.1.2. Dry Powder Inhaler

11.2.1.3. Soft Mist Inhaler

11.2.2. Nebulizer

11.2.2.1. Jet Nebulizer

11.2.2.2. Mesh Nebulizer

11.2.2.3. Ultrasonic Nebulizer

11.3. Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027

11.3.1. Manual Device

11.3.2. Digital Device

11.4. Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

11.4.1. Hospital Pharmacies

11.4.2. Retail Pharmacies

11.4.3. Online Pharmacies

11.5. Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Rest of Europe

11.6. Europe COPD Drug Delivery Devices Market Attractiveness Analysis

11.6.1. By Product

11.6.2. By Type

11.6.3. By Distribution Channel

11.6.4. By Country/Sub-region


12. Asia Pacific COPD Drug Delivery Devices Market Analysis and Forecast

12.1. Introduction

12.2. Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

12.2.1. Inhaler

12.2.1.1. Metered Dose Inhaler

12.2.1.2. Dry Powder Inhaler

12.2.1.3. Soft Mist Inhaler

12.2.2. Nebulizer

12.2.2.1. Jet Nebulizer

12.2.2.2. Mesh Nebulizer

12.2.2.3. Ultrasonic Nebulizer

12.3. Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027

12.3.1. Manual Device

12.3.2. Digital Device

12.4. Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

12.4.1. Hospital Pharmacies

12.4.2. Retail Pharmacies

12.4.3. Online Pharmacies

12.5. Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

12.5.1. China

12.5.2. Japan

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis

12.6.1. By Product

12.6.2. By Type

12.6.3. By Distribution Channel

12.6.4. By Country/Sub-region

13. Latin America COPD Drug Delivery Devices Market Analysis and Forecast

13.1. Introduction

13.2. Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

13.2.1. Inhaler

13.2.1.1. Metered Dose Inhaler

13.2.1.2. Dry Powder Inhaler

13.2.1.3. Soft Mist Inhaler

13.2.2. Nebulizer

13.2.2.1. Jet Nebulizer

13.2.2.2. Mesh Nebulizer

13.2.2.3. Ultrasonic Nebulizer

13.3. Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027

13.3.1. Manual Device

13.3.2. Digital Device

13.4. Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

13.4.1. Hospital Pharmacies

13.4.2. Retail Pharmacies

13.4.3. Online Pharmacies

13.5. Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Latin America COPD Drug Delivery Devices Market Attractiveness Analysis

13.6.1. By Product

13.6.2. By Type

13.6.3. By Distribution Channel

13.6.4. By Country/Sub-region

14. Middle East & Africa COPD Drug Delivery Devices Market Analysis and Forecast

14.1. Introduction

14.2. Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

14.2.1. Inhaler

14.2.1.1. Metered Dose Inhaler

14.2.1.2. Dry Powder Inhaler

14.2.1.3. Soft Mist Inhaler

14.2.2. Nebulizer

14.2.2.1. Jet Nebulizer

14.2.2.2. Mesh Nebulizer

14.2.2.3. Ultrasonic Nebulizer

14.3. Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027

14.3.1. Manual Device

14.3.2. Digital Device

14.4. Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

14.4.1. Hospital Pharmacies

14.4.2. Retail Pharmacies

14.4.3. Online Pharmacies

14.5. Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Israel

14.5.4. Rest of Middle East & Africa

14.6. Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis

14.6.1. By Product

14.6.2. By Type

14.6.3. By Distribution Channel

14.6.4. By Country/Sub-region


15. Competition Landscape

15.1. Competition Matrix

15.2. Market Share Analysis, by Company (2018)

15.3. Company Profiles

15.3.1. AstraZeneca

15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.1.2. Company Financials

15.3.1.3. Growth Strategies

15.3.1.4. SWOT Analysis

15.3.2. Boehringer Ingelheim GmbH

15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.2.2. Company Financials

15.3.2.3. Growth Strategies

15.3.2.4. SWOT Analysis

15.3.3. GlaxoSmithKline plc

15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.3.2. Company Financials

15.3.3.3. Growth Strategies

15.3.3.4. SWOT Analysis

15.3.4. Novartis AG

15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.4.2. Company Financials

15.3.4.3. Growth Strategies

15.3.4.4. SWOT Analysis

15.3.5. Teva Pharmaceutical Industries

15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.5.2. Company Financials

15.3.5.3. Growth Strategies

15.3.5.4. SWOT Analysis

15.3.6. Merck & Co., Inc.

15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.6.2. Company Financials

15.3.6.3. Growth Strategies

15.3.6.4. SWOT Analysis

15.3.7. Cipla Inc.

15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.7.2. Company Financials

15.3.7.3. Growth Strategies

15.3.7.4. SWOT Analysis

15.3.8. Sunovion Pharmaceuticals, Inc.

15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.8.2. Company Financials

15.3.8.3. Growth Strategies

15.3.8.4. SWOT Analysis

15.3.9. Koninklijke Philips N.V.

15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.9.2. Company Financials

15.3.9.3. Growth Strategies

15.3.9.4. SWOT Analysis

15.3.10. PARI GmbH

15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.10.2. Growth Strategies

15.3.10.3. SWOT Analysis

15.3.11. Omron Corporation

15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.11.2. Company Financials

15.3.11.3. Growth Strategies

15.3.11.4. SWOT Analysis
 



List of Figures



Figure 01: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 02: Global COPD Drug Delivery Devices Market Value Share, by Product, 2018

Figure 03: Global COPD Drug Delivery Devices Market Value Share, by Type, 2018

Figure 04: Global COPD Drug Delivery Devices Market Value Share, by Distribution Channel, 2018

Figure 05: Global COPD Drug Delivery Devices Market Value Share, by Region, 2018

Figure 06: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 07: Global COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027

Figure 08: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth, by Inhaler, 2017–2027

Figure 09: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth, by Nebulizer, 2017–2027

Figure 10: Global COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019–2027

Figure 11: Global COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027

Figure 12: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Manual Device, 2017–2027

Figure 13: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Digital Device, 2017–2027

Figure 14: Global COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019–2027

Figure 15: Global COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 16: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies, 2017–2027

Figure 17: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies, 2017–2027

Figure 18: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2017–2027

Figure 19: Global COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 20: Global COPD Drug Delivery Devices Market Value Share Analysis, by Region, 2018 and 2027

Figure 21: Global COPD Drug Delivery Devices Market Attractiveness Analysis, by Region, 2019–2027

Figure 22: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 23: North America COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027

Figure 24: North America COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019–2027

Figure 25: North America COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027

Figure 26: North America COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019–2027

Figure 27: North America COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 28: North America COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 29: North America COPD Drug Delivery Devices Market Value Share Analysis, by Country, 2018 and 2027

Figure 30: North America COPD Drug Delivery Devices Market Attractiveness Analysis, by Country, 2019–2027

Figure 31: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 32: Europe COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027

Figure 33: Europe COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019–2027

Figure 34: Europe COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027

Figure 35: Europe COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019–2027

Figure 36: Figure 36: Europe COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 37: Europe COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 38: Europe COPD Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 39: Europe COPD Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 40: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 41: Asia Pacific COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027

Figure 42: Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019–2027

Figure 43: Asia Pacific COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027

Figure 44: Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019–2027

Figure 45: Asia Pacific COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 46: Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 47: Asia Pacific COPD Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 48: Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 49: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 50: Latin America COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027

Figure 51: Latin America COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019–2027

Figure 52: Latin America COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027

Figure 53: Latin America COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019–2027

Figure 54: Latin America COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 55: Latin America COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 56: Latin America COPD Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 57: Latin America COPD Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 58: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 59: Middle East & Africa COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027

Figure 60: Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019–2027

Figure 61: Middle East & Africa COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027

Figure 62: Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019–2027

Figure 63: Middle East & Africa COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 64: Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 65: Middle East & Africa COPD Drug Delivery Devices Market Value Share Analysis, by Country/Sub region, 2018 and 2027

Figure 66: Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 67: Global COPD Drug Delivery Devices Market Share, by Company, 2018

Figure 68: AstraZeneca Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 69: AstraZeneca Respiratory Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 70: AstraZeneca Breakdown of Net Sales (%), by Product Segment, 2018

Figure 71: Boehringer Ingelheim International GmbH Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 72: Boehringer Ingelheim International GmbH R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 73: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Region, 2018

Figure 74: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Business Segment, 2018

Figure 75: GlaxoSmithKline plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 76: GlaxoSmithKline plc R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 77: GlaxoSmithKline plc Breakdown of Net Sales (%), by Region, 2018

Figure 78: GlaxoSmithKline plc Breakdown of Net Sales (%), by Business Segment, 2018

Figure 79: Novartis AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 80: Novartis AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 81: Novartis AG Breakdown of Net Sales (%), by Country, 2018

Figure 82: Novartis AG Breakdown of Net Sales (%), by Business Segment, 2018

Figure 83: Teva Pharmaceutical Industries Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 84: Teva Pharmaceutical Industries Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017

Figure 85: Teva Pharmaceutical Industries Ltd. Breakdown of Net Sales (%), by Segment, 2018

Figure 86: Merck & Co., Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 87: Merck & Co., Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 88: Merck & Co., Inc. Breakdown of Net Sales (%), by Region, 2018

Figure 89: Merck & Co., Inc. Breakdown of Net Sales (%), by Business Segment, 2018

Figure 90: Cipla Inc., Revenue (US$ Mn), 2015–2018

Figure 91: Cipla Inc., Breakdown of Net Sales (%), Therapy-wise, 2018

Figure 92: Cipla Inc., Breakdown of Net Sales (%), by Region, 2018

Figure 93: Sumitomo Dainippon Pharma Co., Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Figure 94: Sumitomo Dainippon Pharma Co., Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Figure 95: Sumitomo Dainippon Pharma Co., Ltd Breakdown of Pharmaceutical Net Sales (%), by Region, 2017

Figure 96: Sumitomo Dainippon Pharma Co., Ltd Breakdown of Net Sales (%), by Product Segment, 2017

Figure 97: Koninklijke Philips N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 98: Koninklijke Philips N.V. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 99: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Region, 2018

Figure 100: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Business Segment, 2018

Figure 101: Omron Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 102: Omron Corporation (Healthcare Business) R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 103: Omron Corporation (Healthcare Business) Breakdown of Net Sales (%), by Region, 2018

Figure 104: Omron Corporation Breakdown of Net Sales (%), by Business Segment, 2018
 

 

List of Tables



Table 01: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 02: Global COPD Drug Delivery Devices Market, by Inhaler, 2017–2027

Table 03: Global COPD Drug Delivery Devices Market, by Nebulizer, 2017–2027

Table 04: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 05: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 06: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 07: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 08: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017–2027

Table 09: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017–2027

Table 10: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 11: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 12: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 13: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 14: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017–2027

Table 15: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017–2027

Table 16: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 17: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 18: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 19: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 20: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017–2027

Table 21: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017–2027

Table 22: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 23: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 24: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 25: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 26: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017–2027

Table 27: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017–2027

Table 28: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 29: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 30: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 31: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 32: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017–2027

Table 33: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017–2027

Table 34: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 35: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 36: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027